Related Experiment Video
Updated: Jun 11, 2026

Evaluation of Biomaterials for Bladder Augmentation using Cystometric Analyses in Various Rodent Models
Published on: August 9, 2012
Bladder outlet obstruction: progression from inflammation to fibrosis
Peter D Metcalfe1, JianFei Wang, Haiyan Jiao
1Division of Paediatric Surgery, Department of Surgery, University of Alberta, Edmonton, Alberta, Canada. pmetcalf@ualberta.ca
Partial bladder outlet obstruction (pBOO) in rats causes progressive bladder decompensation, including inflammation, smooth muscle hypertrophy, and fibrosis. Early intervention targeting these changes is crucial to prevent long-term damage.
Area of Science:
- Urology
- Pathophysiology
- Animal Models
Background:
- Partial bladder outlet obstruction (pBOO) is a common condition leading to bladder dysfunction.
- Understanding the long-term pathophysiological changes in pBOO is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the progression of urodynamic, histological, and biochemical changes in a rat model of partial bladder outlet obstruction (pBOO) over 13 weeks.
- To establish a physiologically relevant animal model for studying bladder decompensation.
Main Methods:
- Surgical creation of pBOO in female Fischer rats for 2, 4, 8, or 13 weeks.
- Urodynamic measurements, light microscopy, and biochemical analyses (RT-PCR, IHC, mass spectrometry) were performed.
- Key markers assessed included collagen, TGF-β, CTGF, HIF-1α, PDGF-A, and α-SMA.
Main Results:
- pBOO induced progressive changes, including increased bladder capacity followed by decreased capacity and increased pressure.
- Histological analysis revealed inflammation, smooth muscle hypertrophy, and increased collagen deposition (fibrosis).
- Elevated mRNA levels of TGF-β, CTGF, HIF-1α, and PDGF-A, along with increased α-SMA, confirmed the pathophysiological cascade.
Conclusions:
- The rat model effectively replicates clinical pBOO, demonstrating distinct phases of bladder decompensation: inflammation, hypertrophy, and fibrosis.
- The observed time course of inflammatory markers suggests a critical window for early intervention.
- Targeting these physiological responses may lead to improved preventative strategies for bladder dysfunction.
Related Concept Videos
Chronic Inflammation: Introduction
Intestinal Obstruction II: Pathophysiology
Cirrhosis II: Pathophysiology
Chronic Pancreatitis II: Pathophysiology
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis I: Introduction

